Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record, with a small difference in title or year; 38 of the 41 references it cites were found in a registry or an index.

HIF-1 and tumor progression: pathophysiology and therapeutics

Semenza, Gregg L. · 2002 · Trends in Molecular Medicine

Abstract

Hypoxia-inducible factor 1 (HIF-1) controls oxygen delivery (via angiogenesis) and metabolic adaptation to hypoxia (via glycolysis). HIF-1 consists of a constitutively expressed HIF-1 beta subunit and an oxygen- and growth-factor-regulated HIF-1 alpha subunit. In xenografts, tumor growth and angiogenesis are correlated with HIF-1 expression. In human cancers, HIF-1 alpha is overexpressed as a result of intratumoral hypoxia and genetic alterations affecting key oncogenes and tumor suppressor genes. HIF-1 alpha overexpression in biopsies of brain, breast, cervical, esophageal, oropharyngeal and ovarian cancers is correlated with treatment failure and mortality. Increased HIF-1 activity promotes tumor progression, and inhibition of HIF-1 could represent a novel approach to cancer therapy.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1471-4914(02)02317-1

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 41 references

Cited by

See all 1,060

Metadata

Authors
Semenza, G. L.
Affiliations
Johns Hopkins University (US)
Corresponding author
Semenza, Gregg L.
Venue
Trends in Molecular Medicine
Publisher
Elsevier BV
Published
2002-04
Volume
8
Issue
4
Pages
S62-S67
ISSN
1471-4914 (ISSN-L)
OpenAlex
W2072227408
Cited by
1,060
References
41
Citations by year
2026: 23 · 2025: 13 · 2024: 29 · 2023: 29 · 2022: 33 · 2021: 38 · 2020: 21 · 2019: 44 · 2018: 37 · 2017: 37 · 2016: 37 · 2015: 51 · 2014: 47 · 2013: 44 · 2012: 40
FWCI
4.51
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Trends in Molecular Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
Keywords
HIF-1, hypoxia-inducible factor-1α, tumor progression, tumor hypoxia, angiogenesis, glycolysis, intratumoral hypoxia, oncogenes, tumor suppressor, cancer therapy, treatment failure, breast cancer, ovarian cancer, brain cancer, cervical cancer, esophageal cancer, oropharyngeal cancer
MeSH terms
Animals, Antineoplastic Agents, DNA-Binding Proteins, Humans, Neoplasms, Neovascularization, Pathologic, Nuclear Proteins, Oxygen, Transcription Factors, Signal Transduction, Cell Hypoxia, Disease Progression, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HIF-1 and tumor progression: pathophysiology and therapeutics. https://app.cochat.ai/papers/10.1016/s1471-4914(02)02317-1
The paper
Semenza, G. L. (2002). HIF-1 and tumor progression: pathophysiology and therapeutics. Trends in Molecular Medicine. https://doi.org/10.1016/s1471-4914(02)02317-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.